DE WILDE, Mattheus Cornelis,SIJBEN, Johannes Wilhelmus Christina,KAMPHUIS, Patrick Joseph Gerardus Hendrikus,HAGEMAN, Robert Johan Joseph
申请号：
AU2017201766
公开号：
AU2017201766A1
申请日:
2017.03.15
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
#$%^&*AU2017201766A120170406.pdf#####Abstract The invention relates to a composition comprising: i) one or more of uridine and cytidine, or salts, phosphates, acyl derivatives or esters thereof； ii) a lipid fraction comprising at least one of docosahexaenoic acid (22:6； DHA), eicosapentaenoic acid (20:5； EPA) and docosapentaenoic acid (22:5； DPA), or esters thereof, in which the lipid fraction comprises less than 2 weight% of alinolenic acid (ALA), calculated on the weight of all fatty acids； iii) choline, or salts or esters thereof； for use in the prevention or treatment of neurotrauma, traumatic brain injury, cerebral palsy and spinal cord injury.
